SWM
HCAT icon

Shelton Wealth Management’s Health Catalyst HCAT Stock Holding History

Shelton Wealth Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$820 – 174
2025
Q3 		$855 Buy
+300
New +$1.03K ﹤0.01% 150

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Shelton Wealth Management's HCAT Position: Q4 2025 in Review

Shelton Wealth Management sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 300 shares — an estimated $820 sold.

Shelton Wealth Management first reported a position in HCAT in Q3 2025 and held it in 1 quarter. The position peaked at $855 in Q3 2025. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Shelton Wealth Management reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Shelton Wealth Management sold 300 Health Catalyst shares in Q4 2025, an estimated $820.
  • Shelton Wealth Management first reported a position in Health Catalyst in Q3 2025 and held it in 1 quarter.
  • Shelton Wealth Management's Health Catalyst position peaked at $855 in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Shelton Wealth Management's 13F filing for Q4 2025, filed 26 Jan 2026.